The trial data shows slightly higher hair loss rates with tirzepatide (about 5%) versus semaglutide (about 3%), but tirzepatide also produces more weight loss, which to me is the more likely explanation
By reducing your bloods ability to clot, warfarin significantly lowers your risk of dangerous clots that could cause strokes or other serious complications
Answer: Semaglutide is a GLP-1 receptor agonist, a prescription medication originally developed for type 2 diabetes and now FDA-approved for chronic weight management, given as a once-weekly injection that reduces appetite and slows digestion
Some drugs in this class, like semaglutide (sold as Ozempic for type 2 diabetes and Wegovy for weight loss), have recently become FDA-approved for uses beyond type 2 diabetes management, including weight management and reduction of cardiovascular events
Injection angle Place the pen flat against the skin at a 90-degree angle as directed in the Instructions for Use
Tirzepatide (SURMOUNT-1) In adults with overweight or obesity (without type 2 diabetes), average weight loss over 72 weeks was 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg), compared with 3.1% for placebo, alongside lifestyle changes
